AI in the US Blood Transfusion Diagnostics Market

Spread the love

Based on Fortune Business Insights’ report, the us blood transfusion diagnostics market share sector attained a worth of USD 1.91 billion in 2021. Forecasts indicate a promising path ahead, foreseeing a Compound Annual Growth Rate (CAGR) of 7.2% from 2021 to 2029. This trajectory will culminate in a noteworthy achievement of USD 3.58 billion by 2029, highlighting considerable opportunities within this flourishing high-volume industry. North America dominated the market in 2021.

Request a Free Sample PDF Brochure of US Blood Transfusion Diagnostics Market:

In a recent study, Fortune Business Insights presents the nitty-gritty of the global US Blood Transfusion Diagnostics Market considering 2024–2032 as the stipulated timeframe. The business report highlights the drivers, restraints, opportunities, and market growth trends. Further, all the market shares associated with the market as well as the segments are expressed in terms of value and volume.

Top Companies in the US Blood Transfusion Diagnostics Market:

  • QUOTIENT LIMITED (Switzerland)
  • Grifols, S.A. (Spain)
  • Immucor, Inc. (U.S.)
  • Bio-Rad Laboratories, Inc. (U.S.)
  • Merck KGaA (Germany)
  • Beckman Coulter, Inc. (Danaher) (U.S.)
  • QuidelOrtho Corporation (U.S.)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Abbott (U.S.)

The US Blood Transfusion Diagnostics Market study outlines the key regions of North America, Latin America, Europe, East Asia, and Japan along with the countries contributing the most in the respective regions. The report presents detailed insights about each market player, including SWOT analysis, main market information, market share, revenue, pricing, and gross margin.

US Blood Transfusion Diagnostics Market Dynamics:

  • Technological Advancements: Continuous advancements in blood transfusion diagnostics drive innovation in the US market, with new technologies such as nucleic acid testing (NAT), immunoassays, and automation enhancing the speed, accuracy, and safety of blood screening and compatibility testing.
  • Emphasis on Blood Safety: The market experiences growth due to increased emphasis on blood safety measures, including screening for infectious diseases such as HIV, hepatitis, and Zika virus, as well as implementation of pathogen reduction technologies to minimize the risk of transfusion-transmitted infections.
  • Rising Demand for Blood Products: Growing demand for blood products, including red blood cells, platelets, and plasma, in healthcare settings drives demand for blood transfusion diagnostics, ensuring compatibility, quality, and safety of blood products for transfusion recipients.
  • Regulatory Compliance and Standardization: Compliance with regulatory requirements, including FDA regulations, AABB standards, and CLIA certification, influences the development and adoption of blood transfusion diagnostics, ensuring adherence to quality assurance, validation, and proficiency testing protocols.
  • Market Consolidation and Competitive Landscape: The US blood transfusion diagnostics market is characterized by a competitive landscape with key players engaging in mergers, acquisitions, and strategic partnerships to expand product portfolios, geographic reach, and market share, driving competition and innovation in the industry.

The insights for each vendor consist of:

  • Company profile
  • SWOT analysis
  • Main market information
  • Market share
  • Revenue, pricing, and gross margin

Crucial insights in the US Blood Transfusion Diagnostics Market research:

  1. Underlying macro- and microeconomic factors impacting the growth of the US Blood Transfusion Diagnostics Market.
  2. Basic overview of US Blood Transfusion Diagnostics Market, including market definition, classification, and applications.
  3. Scrutinization of each US Blood Transfusion Diagnostics Market player based on mergers & acquisitions, R&D projects, and product launches.
  4. Adoption trend of US Blood Transfusion Diagnostics Market across various industries.
  5. Important regions and countries offer lucrative opportunities to US Blood Transfusion Diagnostics Market stakeholders.

Important regions covered in the US Blood Transfusion Diagnostics Market report include:

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa

Table of Contents:

  • Introduction
    • Research Scope
    • Customer Segmentation
    • Data Gathering Strategies
    • Key Definitions & Caveats
  • Executive Summary
  • Market Dynamics
    • US Blood Transfusion Diagnostics Market Drivers
    • US Blood Transfusion Diagnostics Market Restraints
    • Market Opportunities
  • Key Insights
    • Value Chain
    • Major M&A moves and game-changing partnerships.
    • Covid-19 Impact
  • Future of the Healthcare Industry
  • Competitive Landscape
  • Mergers and Acquisitions, Joint Ventures, Collaborations, and Agreements
  • US Blood Transfusion Diagnostics Market Growth Size 2024
  • Strategies Adopted by Leading Players
  • Company Profiles (Overview, Financials, Products and Services, and Recent Developments)
  • Disclaimer

TOC Continued…!


  1. How big is the US Blood Transfusion Diagnostics Market?
  2. What factors are influencing the US Blood Transfusion Diagnostics Market growth in North America?
  3. Who are the key US Blood Transfusion Diagnostics Market players?

Contact us:


Leave a Reply

Your email address will not be published. Required fields are marked *